MAIA Biotechnology Inc (MAIA)
3.02
-0.34
(-10.12%)
USD |
NYAM |
May 08, 16:00
3.02
0.00 (0.00%)
After-Hours: 20:00
MAIA Biotechnology Total Assets (Quarterly): 7.567M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.567M |
| September 30, 2023 | 7.001M |
| June 30, 2023 | 10.27M |
| March 31, 2023 | 9.074M |
| December 31, 2022 | 12.02M |
| Date | Value |
|---|---|
| September 30, 2022 | 14.78M |
| June 30, 2022 | 9.760M |
| March 31, 2022 | 11.44M |
| December 31, 2021 | 11.33M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
7.001M
Minimum
Sep 2023
14.78M
Maximum
Sep 2022
10.36M
Average
10.27M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 8.805M |
| Avid Bioservices Inc | 455.23M |
| Oragenics Inc | 4.966M |
| NeuBase Therapeutics Inc | 18.62M |
| Viking Therapeutics Inc | 967.52M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.089M |
| Shareholders Equity (Quarterly) | 0.4775M |